Chipiron
Chipiron is a pioneering medtech startup building a disruptive, ultra-low-field (<10 mT) full-body MRI scanner designed to be lightweight, affordable, and operable without shielded rooms or specialized technicians. The company has secured significant non-dilutive grants and equity financing, including a $17M Series A and a major EIC Accelerator award, validating its ambitious vision. With a roadmap targeting first in-vivo images in 2025 and FDA clearance in 2028, Chipiron aims to revolutionize medical imaging by making MRI screening and image-guided therapies accessible on a global scale.
Private Company
Total funding raised: $20.3M
AI Company Overview
Chipiron is a pioneering medtech startup building a disruptive, ultra-low-field (<10 mT) full-body MRI scanner designed to be lightweight, affordable, and operable without shielded rooms or specialized technicians. The company has secured significant non-dilutive grants and equity financing, including a $17M Series A and a major EIC Accelerator award, validating its ambitious vision. With a roadmap targeting first in-vivo images in 2025 and FDA clearance in 2028, Chipiron aims to revolutionize medical imaging by making MRI screening and image-guided therapies accessible on a global scale.
Technology Platform
An integrated ultra-low-field (<10 mT) MRI platform combining a patented quantum SQUID detection system, AI-powered noise cancellation, a lightweight cryostat, and advanced AI reconstruction to enable lightweight, affordable, full-body MRI without shielded rooms.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
Main competitors include incumbent high-field MRI giants (Siemens, GE, Philips) and portable MRI startups like Hyperfine (brain-only) and Synaptive. Chipiron differentiates by targeting a full-body, ultra-portable system using quantum SQUID detection and aiming for radical affordability without shielded rooms.